Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2160765

O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F.c1cc[n+](-c2ccccn2)cc1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 1/20 0.35
NAPRT Q6XQN6 1/20 0.35
P4HTM Q9NXG6 1/20 0.35
KDM4E B2RXH2 3/20 0.34
KCNN1 Q92952 1/20 0.34
KMT2A Q03164 2/20 0.33
DPP4 P27487 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
ALOX15 P16050 1/20 0.33
CYP2C19 P33261 1/20 0.33
CHIT1 Q13231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL10682671 0.79 NAPRT (0.42) TDP1L3MBTL1LMNANAPRTP4HTM
SCHEMBL1551556 0.79 HDAC8 (0.42) TDP1L3MBTL1LMNANAPRTP4HTM
SCHEMBL40911 0.79 HDAC8 (0.42) TDP1L3MBTL1LMNANAPRTP4HTM
Hydrochloric Acid SCHEMBL1882279 0.79 HDAC8 (0.42) TDP1L3MBTL1LMNANAPRTP4HTM
Trifluoroacetic Acid SCHEMBL2073398 0.78 TDP1 (0.41) TDP1KDM4EKCNN1KMT2ADPP4
Hydrochloric Acid SCHEMBL2635755 0.77 HDAC8 (0.41) TDP1L3MBTL1LMNANAPRTP4HTM
Ammonia Solution, Strong SCHEMBL11318385 0.77 HDAC8 (0.41) TDP1L3MBTL1LMNANAPRTP4HTM
Iodide SCHEMBL28626956 0.77 HDAC8 (0.41) TDP1L3MBTL1LMNANAPRTP4HTM
Sulfuric Acid SCHEMBL11318937 0.76 LMNA (0.36) TDP1L3MBTL1LMNANAPRTP4HTM
SCHEMBL10873361 0.75 LMNA (0.35) L3MBTL1LMNANAPRTP4HTMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470823-B2 Saturated bicyclic heterocyclic derivatives as SMO antagonists INSTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.R.L. (IT) 2013-06-25 US disclosed
US-20110183989-A1 SATURATED BICYCLIC HETEROCYCLIC DERIVATIVES AS SMO ANTAGONISTS Instituto di Ricerche di Biologia Molecolare P. Ang 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183989-A1 SATURATED BICYCLIC HETEROCYCLIC DERIVATIVES AS SMO ANTAGONISTS SMO, SHH, GLI1 TDP1 4570/4885L3MBTL1 2984/4885LMNA 4635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.